Delivery Order SPE2D021DA002-SPE2D325F018N

Award Date 4/28/25
Potential Completion Date 4/29/25
Potential Value $4.4K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,460.60, is for the delivery of an Antidote Treatment Kit, Cyanide Sodium N to support the medical supply needs of military healthcare facilities. The contract is not associated with any set-aside designation, which allows DMS Pharmaceutical Group to leverage its...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,460.60 firm fixed-price delivery order is for the procurement of an Antidote Treatment Kit, Cyanide Sodium N, which is a specialized medical product used to treat cyanide poisoning. The contract has an ultimate completion date of November 13, 2024. DMS...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,460.60 firm fixed-price delivery order is for an "Antidote Treatment Kit, Cyanide, Sodium N" and has a performance period ending on September 20, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $6,718.76, is a firm fixed-price delivery order for an Antidote Treatment Kit, Cyanide Sodium N under the DLA's SPE2D program. The contract has an ultimate completion date of December 24, 2024. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery...
This federal contract award, with an ID of SPE2D021DA002|SPE2D325F0926, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of an Antidote Treatment Kit, Cyanide Sodium N, and has a ceiling value of $1,460.60. The contract is a firm fixed-price delivery order, with an ultimate completion date of October 29, 2024. DMS Pharmaceutical Group Inc. is...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,358.75, is for the delivery of ANTIDOTE TREATMENT supplies and has an ultimate completion date of October 3, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,343.50 contract is for the delivery of "ANTIDOTE TREATMENT" products, with a completion date of April 25, 2024. This award is part of DMS Pharmaceutical Group's broader prime vendor contracts with DLA and other government agencies, including...
This federal contract award, identified as SPE2D021D0004|SPE2D025F0200, was made by the Medical Supply Chain office of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,606.66 fixed-price delivery order is for the provision of "ANTIDOTE TREATMENT" products to support the recurring medical supply needs of military healthcare facilities. The contract is not associated with any set-aside designation,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has a ceiling value of $3,100.80 and is for the delivery of antidote treatment products. This contract is not set aside for any specific business category. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $2,129.16 firm fixed-price delivery order is for the supply of CYANOKIT 5 gram vials, a specialized pharmaceutical product. The contract has an ultimate completion date of April 3, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables...
  • SPE2D021DA002
    Indefinite Delivery Contract
  • SPE2D021DA002-SPE2D325F018N
    Delivery Order

This is a federal contract award by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $4,381.80, is for the delivery of Antidote Treatment Kits, Cyanide Sodium N. The contract is a firm fixed-price delivery order, without any set-aside designation.

DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting the medical supply needs of military health facilities worldwide. The contract covers an extensive portfolio of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories.

Generated 7/28/25, 11:09 AM